Charlotte Glinge Selected Research

Charlotte Glinge Research Topics

9	ST Elevation Myocardial Infarction 11/2023 - 01/2015
4	Ventricular Fibrillation 10/2023 - 01/2015
3	Atrial Fibrillation 01/2021 - 01/2017
3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 10/2020
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2024 - 01/2017
2	Hemorrhage 11/2023 - 01/2021
2	Brugada Syndrome 05/2022 - 01/2022
2	Disease Susceptibility (Diathesis) 05/2022 - 01/2022
2	Myocardial Infarction 11/2021 - 01/2017
2	Ischemic Stroke 11/2021 - 01/2021
1	Infarction (Infarctions) 10/2023
1	Ischemia 10/2023
1	Acute-Phase Reaction 10/2023
1	Heart Failure 01/2022
1	Reperfusion Injury 01/2022
1	Heart Arrest (Cardiac Arrest) 10/2020
1	Hypokalemia 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018
1	Death (Near-Death Experience) 01/2017
1	Sudden Death 01/2017

2	Clopidogrel (Plavix)FDA Link 11/2023 - 11/2021
2	Prasugrel Hydrochloride FDA Link 11/2023 - 11/2021
2	TicagrelorIBA 11/2023 - 11/2021
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
2	Sodium Channels (Sodium Channel)IBA 05/2022 - 01/2022
1	omega-Chloroacetophenone (Mace)IBA 11/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2023
1	Blood Proteins (Serum Proteins)IBA 10/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	AnticoagulantsIBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2021
1	dimemorfan (AT 17)IBA 01/2021
1	PotassiumIBA 01/2020
1	LipidsIBA 11/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017

8	Percutaneous Coronary Intervention 11/2023 - 01/2015
3	Therapeutics 11/2023 - 10/2020
1	Polypharmacy 04/2024
1	Stents 11/2023
1	Catheters 10/2023
1	Thrombectomy 01/2022
1	Ischemic Postconditioning 01/2022
1	Resuscitation 01/2020
1	Drug Therapy (Chemotherapy) 01/2017